Can a Crohn's disease drug lead to complete healing? Real-World study investigates
NCT ID NCT05192863
Summary
This study observed adults with moderate to severe Crohn's disease who started treatment with the drug vedolizumab in real-world clinic settings. Researchers followed 72 patients for 18 months to see if the treatment could lead to complete remission—meaning no symptoms, normal blood/stool tests, and healed bowel walls seen on ultrasound—without needing steroid medications. The goal was to understand how well this existing treatment works to control the disease long-term.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
A.O.U. Federico II
Naples, 80131, Italy
-
ASST Fatebenefratelli Sacco
Milan, 20157, Italy
-
Fondazione Ca' Granda Ospedale Maggiore Policlinico
Milan, 20122, Italy
-
Hadassah Medical Center
Jerusalem, 9112001, Israel
-
Ospedale ASST Rhodense
Rho, Milano, 20017, Italy
-
Ospedale San Raffaele
Milan, 20132, Italy
-
Rabin Medical Center
Petah Tikva, 4941492, Israel
-
Sheba Medical Center
Ramat Gan, 5262000, Israel
-
University of Calgary
Calgary, Alberta, T2N 4N1, Canada
-
University of Saskatchewan
Saskatoon, Saskatchewan, S7N 0W8, Canada
Conditions
Explore the condition pages connected to this study.